Clinical Trials Logo

Fibromyalgia, Primary clinical trials

View clinical trials related to Fibromyalgia, Primary.

Filter by:
  • Not yet recruiting  
  • Page 1

NCT ID: NCT06424743 Not yet recruiting - Chronic Pain Clinical Trials

Preference of Women With Fibromyalgia Undergoing a Three Different Volumes of Resistance Training

Start date: July 1, 2024
Phase: N/A
Study type: Interventional

Fibromyalgia is a painful syndrome of unknown etiology, which affects 2% of world population, with symptoms such as: pain, unrefreshing sleep, fatigue and mood disorders. It is already established in the literature that resistance training is part of the non- pharmacological treatment for patients with fibromyalgia. The big gap is about the quantity adequate and/or recommended exercise volume, despite some studies with exercise volumes different resistance trainings show improvements, we do not have a direction, besides We still do not know whether there is a preference for these patients in different resistance training volumes.

NCT ID: NCT05688787 Not yet recruiting - Clinical trials for Fibromyalgia, Primary

Efficacy of Perineural Injection Therapy in Primary Fibromyalgia

Start date: April 1, 2023
Phase: N/A
Study type: Interventional

The goal of fibromyalgia Treatment is to relieve the pain and improve quality of life and physical function which need a Final Version: April 2019Research Template 3 multifaceted treatment approach involving non pharmacological pain management and medicine Lyftgot perineural injection therapy "lyftgot PIT" previously known as neural prolotherapy , is a method of injection treatment designed and developed by DR Lyftgot from new Zealand to treat the neurogenic inflammation and the neuropathic pain caused by the sensocrine small nerve fiber .PIT is based on the injection of small amount of dextrose 5%in a neutral PH sterile water solution in the subcutaneous tissue around the sick nerve to correct the neuroglycopenia and to inhibit the neurogenic inflammation.